a large variety of physiologic, kinetic, and selfreported measures 9 ranging from electrocardiography, electromyography, respiration rate, pulse oxygenation, blood glucose, blood pressure, heart rate, body temperature, and burnt calories 10 to movements of body parts, number of steps, walking speed, sleeping hours, and energy expenditure. In addition, these devices are usually easy-to-use, reliable, widely available and low-cost, allow continuous and non-intrusive monitoring at home for a long time (weeks, months, or years). Moreover, these technologies give the opportunity to measure objective outcomes allowing to deliver feedback on physical activity. 11, 12 Wearables represent promising tools also in multiple sclerosis (MS), offering the possibility to create more objective, less rater-dependent functional outcomes with the potential for more sensitivity to changes over shorter time intervals than physical exam-based metrics. 13 Wearables can be used to support disease monitoring (e.g. falls detection and autonomic functions), self-management (e.g. fatigue, tremor, and ataxia), and treatment (e.g. motor, cognitive, and psychological). However, the research on their application in MS is still ongoing and further studies are required to assess their validity, reliability, and accuracy to monitor body functions and disability in people with MS (pwMS). 14 Here, we will provide a comprehensive overview of the opportunities, potential challenges, and limitations of the use of the wearable technology in MS. Moreover, we will draw some practicalities of its upcoming widespread implementation in routine practice as well as future potential therapeutic benefits in order to move beyond center-based testing.
Overview
Recently, it has been shown that the majority of studies (about 50%), which have explored the use of biosensors in MS, included accelerometers. Gyroscopes were considered only in about 20% of cases, whereas the remaining part was constituted by an array of diverse sensors (e.g. pedometers, portable electromyography, body skin thermometer probe, muscle strength meter, eye trackers). 14 Moreover, by limiting to physical activity, the accelerometers use was found to be even more prominent. 15, 16 This result is not unexpected because the biosensors used in MS as well as in other chronic diseases are mainly devoted to get a comprehensive assessment of activity and function, easily possible with measures obtainable from accelerometers (e.g. steps number and frequency and duration and intensity of physical activity).
In order to better understand the functioning, feasibility, and use of wearables in pwMS, as recently proposed, 17 we classified the experiences found in the literature into macro-categories considered crucial for disease management: assessment, monitoring, intervention, and advice and education (Table 1) .
Assessment
To date, the majority of the studies using wearables to assess pwMS' functions still rely on laboratory settings, 18 although efforts toward a free-living movement context are increasing. 19, 20 Instrumented versions of standard tests have been developed as complement of basic clinical and self-reported outcomes providing additional and finer information and making more reliable the assessment. 11 Inertial sensors such as gyroscopes and accelerometers, allowing a reliable determination of posture changes, can be the main candidate for the balance and mobility assessment. 21 The Timed Up and Go (TUG), one of the most common tests to evaluate dynamic balance, has been integrated with motion sensors in a range of clinical conditions. 22 A recent validation of a model of instrumented TUG in pwMS revealed that the movement of the thigh during the sit-to-stand transition was the most informative of all the measured body segments. 23 This evidence opens interesting views on the possible implementation of a reliable, accurate, and user-friendly TUG based on a smartphone simply positioned in the patient's pocket. 24 Gyroscopes have been also used to distinguish differences in assessing upper limb tremors, 25 movement patterns and speed at several disease severity levels. In particular, the use of a gyroscope allows to catch subtle changes in posture providing information about acceleration and angle of force during motor activities. This information can be used to identify falls, activities such as climbing and descending stairs, as well as in the analysis of static and dynamic balance. 26 Gyroscope, set in mobile devices, may provide an available and affordable solution to augment subjective clinical assessments that may be sometimes distorted due to an inaccurate self-perception, with objective and quantitative measures leading to a more precise diagnosis and to the design of more personalized treatment and rehabilitation programs. 27 Monitoring Accelerometers and other track monitor systems (e.g. global positioning system (GPS)), embedded in smartphones and smartwatches, have been tested to be more objective and ecological tools also for gait monitoring. In particular, lower accelerometer-based step counts were associated with slower gait speed, increased falls risk, and reduced cadence. 28, 29 Similarly, pressure sensors, instrumented insoles placed or integrated into shoes to measure changes in foot-ground pressure, are resulted to be sensitive to detect gait dysfunction in pwMS. 30 Moreover, although the results of the correlation between disability and outcomes of gait from these sensors are encouraging, instrumented gait analysis cannot be fully considered a potential replacement of Expanded Disability Status Scale (EDSS) and self-EDSS 26, 31 but rather may be adopted as additional information missed by EDSS in terms of disability levels. 32 Indeed, there are several factors that limit the usability of these novel devices. For instance, the absence of a standardized protocol (e.g. consistent instruction that guide both the patient and the health professional), and an unintended variability (e.g. patients' unpredictable movement performance and heterogeneity in the way neurologists and patients interact with each other's) may be extremely problematic for machine-learning algorithms embedded in these devices. To this aim, ASSESS MS project represents a promising and innovative tool designed to facilitate more standardized data capture to support movement analysis, while being both usable and acceptable by patients and health professionals in clinic setting using depth-sensing computer vision. 33 To this aim, ASSESS MS movement protocol contains six movements chosen from the EDSS to provide a quantitative measure of the function of upper and lower extremities. Although this study shows the potential of shifting sensing technologies from research into the clinic, novel systems that successfully provide a reliable and accurate clinical assessment of motor skills remain actually "in progress." This did not allow us to draw conclusion about a full replacement of EDSS measurement in favor of new health-care applications. Therefore, additional research is required in order to create a more robust agreement about its validity and use.
Moreover, only few studies have recorded activity of pwMS for long time during their daily-living activities. Since the use of accelerometers and gyroscopes allows to collect great amount of data over time and to detect small changes in the patients' behavior, further studies are needed to evaluate and validate the utility and feasibility of continuous long-term monitoring 34, 35 in order to promote early (self)-intervention.
Wearable biosensors are also able to monitor physiological parameters such as skin conduction, heart rate, blood pressure, pupillary response that are usually considered to objectively measure stress, 9 the correlation between autonomic regulation and fatigue, 14 and the relationship between fatigue and gait. 36 Although few results are available, such investigations will potentially provide more insights about autonomic dysfunctions, central fatigue, stress factors, and their relationship with sleep. 14 Many apps for the self-reporting of symptoms information have been developed to support MS monitoring; however, to date, few tools have been published and translated in all languages. The Novartis SymTrac prompts patients to monitor their symptoms and well-being over time and, in this way, helps to identify when relapses occur. 37, 38 My MS Manager allows the patient to store medical information, track disease activity, generate private reminders, and share disease progression details with the personal physicians. 39 MSdialog is an Internet-and mobilebased app able to capture remote data on clinical and patient-reported outcomes and on self-administration of interferon β-1a and share the information with their physicians; moreover, data from the app are combined with information captured by RebiSmart, an adjustable electronic injection device. 40, 41 Similarly, MSJournal and myBETAapp have been developed to help patients and caregivers to track injections and injection-site history and to set reminder alerts for injections. 42, 43 Intervention As reported by Yousef et al. 14 very limited evidences are present in the literature about the wearable devices use for rehabilitation and physical activity aims. Only few clinical trials considered wearables to increase the effectiveness of the interventions. Improvements during a rehabilitative treatment based on exergames could be obtained using real-time biofeedback delivered by the wearable, already demonstrated to be effective in MS studies using balance boards and cameras. 44 Despite the use of wearable devices for MS interventions is restricted to ongoing clinical trials, in the last years, the number of apps for rehabilitation of cognitive and physical domain has proliferated taking advantages of the multiple sensors embedded in portable devices (i.e. smartphone and tablet) and Web opportunities. 45, 46 For instance, Motl et al. 47 provided evidence for the efficacy of an Internet-based behavioral intervention delivered through interactive video courses for increasing physical activity and possibly improving secondary outcomes of fatigue, depression, anxiety, and walking impairment/disability in persons with MS. 47 MAPSS-MS, developed by Stuifbergen et al., 48 is an interesting tool able to help the individual to acquire the highest level of cognitive functioning and functioning independence through teaching the use of compensatory skills, retraining skills, and environmental/ lifestyle support for cognitive functioning. 48 Results indicate that after the 2-month MAPSS-MS intervention, participants showed statistically and clinically significant improvements in use of compensatory strategies and verbal memory among pwMS experiencing moderate cognitive deficit.
Advice and education
Although largely responsible for administering their disease-modifying therapies and rehabilitative treatments and managing symptoms, pwMS face an "Inverse Information law," which means that the access to appropriate information is particularly difficult to those who need it the most. 49 As for interventions, the use of wearables to deliver advice and promote education among pwMS is very limited and no evidences can be found in the literature. However, several apps for smartphones, mainly based on Web services, have been developed to provide advice and education to pwMS. In particular, to allow to gain insight about their health status and to manage their disease, to empower to become more active in their health care and to stimulate to regularly undertake exercises at home. 50 To this aim, Finkelstein and Wood 51 developed a home automated telemanagement (HAT) system to monitor patient symptoms, educate patients on their disease, and to determine an exercise regimen tailored to the patient's specific needs through at-home remote connection. 51 A further interesting attempt to gather information about disease management of pwMS was developed by Turner et al. in 2013. In a pilot study, participants were asked to respond to a standardized set of questions addressing common MS-related symptoms. Responses from this disease-management protocol were first forwarded to a secure Web portal that could display data graphically and stratify them by importance (e.g. low fatigue, moderate fatigue, and extreme fatigue) and then were monitored by a care coordinator who alerted treating providers about the presence of significant symptoms. 52
Limitations
The increasing technological progress makes available on the marketplace devices (e.g. smartphone and smartwatches) embedding multiple sensors smaller, usable, low-cost, and, consequently, easier to be accessed by a large number of patients.
Despite the amount of studies on wearables is greatly increased in the last decade showing a preference for motion sensors such as accelerometers and gyroscopes, probably due to their good-to-excellent accuracy and reliability also demonstrated in assessing and monitoring physical activity of pwMS, 26,32,53 the current knowledge on the role of wearables in MS is still fragmented and does not allow a standardized use in either clinical or research practice. To date, only few studies compared several sensors of the same type in measuring activities of pwMS. For example, uni-axial and triaxial accelerometers show similar reliability and correlation with disability; 30 however, guidelines on which should be used in clinical practice are absent. Moreover, technical requirements to obtain optimal outcomes are still unclear suggesting more research efforts in order to reach more uniformity. 26 Another major point that needs more clarity concerns the body location where the sensor should be worn. Some authors suggested that a waist-worn accelerometer is the most precise and accurate way to measure movement, 54 since it is close to the mass center of the human body. Other authors, comparing the results of an actigraph positioned in two different locations (wrist vs ankle) in pwMS and healthy subjects, show similar activity patterns in the two groups, although the placement of sensor on the wrist was better tolerated. 20 Overall, combining more accelerometers on the body and, if possible, locating them on both upper and lower limbs significantly improve the human activity recognition. 4 As expected, the integration of different types of devices seems to provide better data quality and help to correct the inaccuracies of single-device solutions. 14 In multi-sensor systems, one sensor is used to enhance the interpretation of a second sensor. Configurations with accelerometers and gyroscopes are common, 55 but the integration of accelerometer and air pressure sensor is also used to improve data collection and the detection of changes in pwMS gait. 19 Although these studies provided evidence supporting the concept that functional limitations due to MS may be better derived from multi-sensor evaluations, future research is needed to determine the sensitivity and reliability of solutions integrating more wearables. 14 In addition, with regard to other biosensors that may help to evaluate the disability extent, to monitor symptoms and to provide real-time feedback in MS (e.g. heart rate detectors, eye trackers, and ectodermal activity monitors), additional research is required in order to create a more robust agreement about their validity and use. 33, 36 Another factor that may limit the application and use of wearable biosensors in the study of MS is patient adherence. Indeed, patients may be reticent to adhere to the protocol out of inconvenience or concern about the appearance of the sensor; 56 however, at least one study has suggested that this is not likely to be a major impediment. Nevertheless, adherence should be taken always into account when wearables are used in the clinical practice in order to avoid mistakes in profiling motor and cognitive status of the patient.
Although the knowledge regarding how depressive and mood symptoms in pwMS vary over time and how they are influenced by contributing factors is still limited, a recent study 57 showed that almost half pwMS had depressive symptoms at least once over the 2-year investigation time period. Wearables could largely support health-care services in developing strategies aimed at identifying pwMS who are depressed or could develop depression due to the disease 58 in order to better plan interventions for alleviating depressive symptoms and, consequently, facilitate the ability to maintain participation in valued everyday activities.
Opportunities and future challenges
Besides the aforementioned limitations that should be transversally taken into account in the design process of these devices, the ongoing technological evolution of wearables creates potential and intriguing challenges for researchers.
User's education and supervision
A crucial aspect to be considered in designing clinical assistance programs or research trials involving the use of wearable technologies concerns the active involvement of the user. Indeed, while in clinical practice, the clinician usually decides and administers tests and treatments, and in the context of self-monitoring and self-management with wearables at home, the patient should be autonomous in using these devices. With the diffusion of smart interacting devices such as smartphones and smartwatches, the user is increasingly able to plan his or her own interventions (e.g. training exercises), to real-time monitor the outcome parameters (e.g. heart rate during exercise) and easily access to the results obtained (e.g. distance covered, mean velocity, and burnt calories). This scenario implies two critical aspects. First, the patient should be very well instructed on the correct technical device use, including optimal positioning, proper recording procedures and timely recharging processes. Second, the patient should be educated to the basic physiopathological mechanisms regarding his or her own specific condition in order to appropriately interpret changes in the recorded parameters and consequently activate the most correct actions to face a potential decay. Delivering devices to non-educated users may lead to wrong understand information and biofeedback and to plan useless or dangerous training (e.g. performing an aerobic training session at too low or too high heart rate). This is even more important in pwMS, who should be taught to recognize acute (i.e. relapses) and chronic (i.e. disability progression) changes due to the disease in order to be able to tune their own monitoring and/or intervention programs. Moreover, it is very difficult for a single clinician to manage all areas of the disease and know all the current possibilities to assess, monitor, and treat pwMS. It is likely that educational programs will be needed as part of training within health-care systems to help clinicians understand the value that various communication technologies such as wearables could bring to routine patient assessment and to ensure that are adopted and applied with standardized methods and reporting. A new figure of digital health-case manager is advocated for the management of such a complex disease. 59 What system to which patient? The heterogeneity of personal and clinical characteristics of pwMS, ranging from younger, active, and autonomous individuals to older, sedentary, and dependent persons, leads to a wide spectrum of symptoms and different needs. Consequently, not all devices are suitable for every patient. When dealing with these devices, we should never forget to ask one A typical example is related to the walking speed. Previous studies provided evidence of decreased accuracy of accelerometers in detecting the number of step for walking speed which is less than 0.89 m/s in both healthy subjects and pwMS. 60 As a consequence, low accuracy in step-count measurement was associated with EDSS > 6, and the use of accelerometers is not recommended for gait detection of severely disable pwMS. 14, 60 On the contrary, the use of accelerometer or pedometer could be suitable only for minimally and mildly impaired pwMS. 20 Due to these considerations, it could be proposed for pwMS with mild or moderate disability, usually youngand middle-aged adults, an at-home care system that integrates data of regular walking self-assessment sessions self-administered through smartphone and data from continuous monitoring through smartwatches or bracelets. 20 On the contrary, for patients with severe disability, in order to prevent from limitation in the accuracy of step-count measurements, a shift of the sensor location from the patient's body to the prosthetic aid (e.g. crutch and wheelchair) or to the daily-living objects may provide more reliable measures of motion and functional abilities.
Beyond center-based testing
Increasing evidence on the efficiency of the Public Health Systems and on the limits of resources available for therapeutic interventions as well as the technical advancements that might lead to the implementation of wearable-based tools in routine practice with high therapeutic benefits, indicate that for pwMS the time is right to shift from the center-based traditional therapeutic paradigm toward a personalized patient-based disease self-administration ( Figure 1 ). To this aim, the collection of continuous mobile health streaming data from multiple wearable sources in a secure, highly scalable, interoperable, and extensible platform is of high interest. MS DataConnect 61 (consortium leads by the University of Hasselt) connects national and international partners involved in MS care, rehabilitation, and research with partners involved in IT development, database management, data-sharing procedures, statistics, machine learning, and prediction modeling in order to move forward in developing standards for interoperability of different data sources.
The European Union (EU) Innovative Medicines Initiative (IMI) Remote Assessment of Disease and Relapse-Central Nervous System (RADAR-CNS) program is an exemplar project aimed to support collection of high-resolution data from a large number of pwMS besides people suffering depression or epilepsy. The possibilities offered by wide-bandwidth networks, smartphone penetrance, and wearable sensors have allowed to build a platform that would cater for large-scale data collection for remote monitoring initiatives. In fact, the RADAR-base platform, by following key criteria such as scalability, extensibility, security, and privacy, is designed to meet these needs and additionally facilitate a new generation of projects in the field of mobile health. 62 The platform is developed in a modular way and provides two main mobile apps for data collection, a Passive App and an Active App. Moreover, other third-party apps and sensors are easily integrated into the RADAR-base platform. MS studies using RADAR-base platforms are underway at different partner sites across Europe. The recruitment has been started and data is being streamed to the central deployment.
Another ongoing initiative supported by Italian MS Foundation (FISM/2016/S3-MappingMS) aims at implementing a continuous monitoring of physical, cognitive, and emotional status for the disease selfmanagement of pwMS. The monitoring system is based on smartphone and wearable unobtrusive technology. The system support pwMS, checking their level of performance in the daily life and inducing, when needed, a behavioral change or an intervention from healthcare professionals. When monitored performance goes below a predefined and personalized threshold of physical, cognitive and emotional parameters, an ad hoc App invites pwMS to self-administrate appropriate physical, cognitive, and/or emotional tests, respectively. The intervention provided by each healthcare professional is activated only when performance goes below a second threshold indicating a major worsening. By providing timely and appropriate care interventions, MappingMS could have a strong impact on the integrated care pathways also allowing costs reduction. Moreover, it could contribute to empower patients to be themselves actors in the management of their health. 63 
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The author(s) received no financial support for the research, authorship, and/or publication of this article. In a center-based care system (left), usually a professional (neurologist, MS society physician) acts at the center of the patient management process. The communication flow is mainly conveyed toward the client and decisions on the best care to be delivered are taken through different clinic-oriented tools, such as standard tests and instrumental exams. As a result, a plan including periodic assessments, pharmacological treatments, and rehabilitative interventions is defined. In a patient-based care system (right), the client is actively involved in the process. Thanks to user-friendly patient-oriented tools, such as smartphones, actigraphs, and other portable/wearable devices, the patient could continuously self-monitor his or her health-care status and better prevent eventual changes due to the disease progression. Wearable technologies may also provide feedback in order to stimulate a correct lifestyle according to the individual abilities and functions (e.g. amount of daily physical activity and safe heart rate range of exercise). In this model, the communication flow is mainly conveyed from the client toward a multidisciplinary medical team, which could be asked to intervene directly by the patient or through automatic alert messages generated by the wearables. Although the patient is thought to be autonomous; however, he or she should never be alone: continuous education and supervision are necessary between patients and professionals. Examples of published or ongoing works are provided in the figure. For a more exhaustive reference list please see Table 1 .
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